This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS Aug. 23, 2011
ASCLS eNewsBytes
Aug. 23, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Fetal genetic testing: A troubling technology
msnbc.com    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have been making rapid progress in identifying which of your genetic traits may be associated with the risk of getting a wide variety of diseases. That's a good thing. They have also been making rapid progress in getting access to genetic material during pregnancy, according to a new report. That means expectant parents may be able to accurately tell what sex the baby will be as early as seven weeks into a pregnancy. That's troubling. More



HIV in America: Studies zero in on trouble spots
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. health experts are turning to sophisticated computer mapping technology and electronic medical records to identify pockets of Americans most at risk of HIV infection. In one study, researchers saw big improvements in rates of HIV testing when they added reminders to patients' electronic health records about the need for routine testing. More

Why stress causes DNA damage
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For years, researchers have published papers that associate chronic stress with chromosomal damage. Now researchers have discovered a mechanism that helps to explain the stress response in terms of DNA damage. More

STA Coag ConneXion

STA Coag ConneXion is an easy to use, Windows 7 based user interface that offers comprehensive QC management, remote QC capability and standardized result reporting with the use of expert rules for auto validation. For more information on STA Coag ConnneXion, visit www.stago-us.com.


Celiac disease on the rise in the US
HealthDay via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Complaints of celiac disease are on the rise in the United States, with more and more people growing ill from exposure to products containing gluten. Nearly five times as many people have celiac disease than during the 1950s, according to a recent study. Another report found that the rate of celiac disease has doubled every 15 years since 1974 and is now believed to affect one in every 133 U.S. residents. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.
MORE




Breakthrough could lead to effective treatment for Lou Gehrig's disease
Chicago Tribune via Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers say they have found a common cause behind amyotrophic lateral sclerosis, better known as Lou Gehrig's disease, that could lead to an effective treatment. Dr. Teepu Siddique, a neuroscientist, said the key was the discovery of an underlying disease process for all types of ALS. More

Mammogram rates declined after women gave up hormone therapy
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
American women who gave up hormone therapy after a study linked the menopause treatment to breast cancer and heart disease also cut back on mammograms, perhaps as a result of fewer doctor visits, researchers said. Mammography rates fell in 2005 for the first time since at least 1987, stumping public health officials who recommend routine use to detect small, easier-to-treat tumors. More



At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or www.phadia.us.


Researchers show gains in finding reusable drugs
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a bit of high-tech recycling, researchers have developed an innovative way to identify already-approved drugs that may work against diseases they weren't designed to combat. The scientists have also demonstrated how a couple of such repurposed drugs may have benefits in treating two conditions, inflammatory bowel disease and lung cancer. More

Stem cells, the new insurance
SA Time via Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When a new baby is on the way, parents start planning and dreaming about their child's future. Everything from nursery to university is discussed and planned. But one aspect of a child's future that you can't plan for is their health, with the worst scenario being a fatal illness ... until now. More

HE4 - New Biomarker for Ovarian Cancer

Fujirebio Diagnostics, Inc. introduces a HE4 EIA assay for the quantitative determination of HE4 in human serum. It is intended for use as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. MORE


Imaging probe allows noninvasive detection of dangerous heart-valve infection
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A novel imaging probe, developed by Massachusetts General Hospital, investigators may make it possible to diagnose accurately a dangerous infection of the heart valves. In their Nature Medicine report, the team from the MGH Center for Systems Biology describes how the presence of Staphylococcus aureus-associated endocarditis in a mouse model was revealed by PET imaging with a radiolabeled version of a protein involved in a process that usually conceals infecting bacteria from the immune system. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Aug. 16, 2011
  • Aug. 9, 2011
  • Aug. 2, 2011
  • July 26, 2011
  • July 19, 2011
  •  RSS Feed
    Most popular articles